Barron's

Advertisement

Bullish Earnings Shine as It Moves Beyond Crypto Trading. A Deal and Buybacks Are in the Works.

Bullish Earnings Shine as It Moves Beyond Crypto Trading. A Deal and Buybacks Are in the Works.

Recurring services revenue and a pending $4.2 billion Equiniti deal are helping Bullish weather sluggish digital-asset volumes.

2 minute read

TJX Sees Holiday Sales Accelerating After Strong Third-Quarter Rebound

TJX Sees Holiday Sales Accelerating After Strong Third-Quarter Rebound

Upbeat holiday commentary and a solid third quarter give shares of the T.J. Maxx parent a much-needed boost.

4 minute read

Advertisement

November 16, 2026

Even in Crisis, Nvidia Stock Is Still a Buy

Even in Crisis, Nvidia Stock Is Still a Buy

Nvidia’s stock hasn’t worked for a while now, and that was with Jensen Huang as CEO. His surprise resignation is a chance for investors to reassess.

Long Read

Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.

Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.

The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.

3 minute read

Why Pfizer Is Tapping Private Equity to Back Its Once-Monthly Weight-Loss Drug

Why Pfizer Is Tapping Private Equity to Back Its Once-Monthly Weight-Loss Drug

Blackstone Life Sciences agrees to pay $1.5 billion in development costs for Pfizer’s berobenatide through 2028 in exchange for milestone-based payments.

2 minute read

Half of Our ‘Big Money’ Managers Say the AI Boom Has Years Left to Run

Half of Our ‘Big Money’ Managers Say the AI Boom Has Years Left to Run

Optimists cite robust earnings growth; the pessimists see a bubble in danger of bursting. Plus, pro forecasts for rates, international markets, the midterm, and more.

Long Read

Don’t Fret the War. Why ‘Big Money’ Investors Are Bullish—and Where They’re Investing Now.

Don’t Fret the War. Why ‘Big Money’ Investors Are Bullish—and Where They’re Investing Now.

In our latest Big Money poll, professional investors are more upbeat than six months ago and see plenty of opportunities for stocks. Where they’re putting money to work.

Long Read

Airline Stocks Bounce Back as Travel Chaos Eases

Airline Stocks Bounce Back as Travel Chaos Eases

Carriers’ shares got a boost on Monday, as the worst of the weekend’s travel chaos looks to be over.

1 minute read

Why Diamondback Is Betting Billions for a Bigger Cut of Future West Texas Wells

Why Diamondback Is Betting Billions for a Bigger Cut of Future West Texas Wells

Buying out Double Eagle’s 40% stake lets Diamondback capture more revenue from wells it was already planning to drill.

3 minute read

EP Wealth Advisors Acquires $1.4 Billion Bay Area Investment Advisor Firm

EP Wealth Advisors Acquires $1.4 Billion Bay Area Investment Advisor Firm

The addition of Lodestar Private Asset Management brings a roster of wealthy clients including many Silicon Valley owners and executives.

2 minute read

Concurrent Recruits Big Raymond James Team as Assets Surge Nearly 80% in 2026

Concurrent Recruits Big Raymond James Team as Assets Surge Nearly 80% in 2026

The latest addition to Concurrent’s platform continues a year of rapid growth with assets under management now topping $30 billion.

2 minute read

Check out Barron's Advisor Rankings

Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.

Find an Advisor

Are you ready to search for a financial advisor? We'll match you with advisors who can help.

Advertisement

(Eastern Time Zone)

Recently Viewed Tickers

SymbolPriceChange% Chg

Advertisement

U.S. Stock Movers

Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000

Company (Ticker)Change PercentPrice
Akanda Corp. (AKAN)87.80% $3.85
ClearOne Inc. (CLRO)60.81% $7.59
SkyAI Inc. (SKYA)58.93% $3.45
Cue Biopharma Inc. (CUE)49.82% $4.24
Netcapital Inc. (NCPL)32.49% $3.14
View full table View extended-hours trading page

Advertisement

Advertisement